Medtronic has recalled nearly 2,000 units of its MiniMed 640G insulin pumps, according to a notification posted on the U.S. Food and Drug Administration’s (FDA’s) website. The device was distributed in the following 10 European countries: Australia, Czech Republic, Denmark, Finland, France, Ireland, the Netherlands, Norway, Sweden and the United Kingdom. Medtronic intends to submit the pump for PMA submission later this year, Fierce Medical Devices reports.
According to the recall notice, there may be instances where “the set Bolus screen will not timeout, which could cause confusion by showing a bolus amount that is no longer appropriate.” The recall was designated as Class 2 by the FDA, meaning that exposure to the recalled device might lead to temporary or reversible adverse events or that there is a low risk of serious events.
On June 19, Medtronic sent a letter to customers informing them of the inaccurate bolus screen issue. The company instructed customers to not activate bolus insulin delivery based on a blood glucose value older than 12 minutes.